Re: First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial. K. O. Kagan, R. Sroka, J. Sonek, H. Abele, K. Lüthgens, M. Schmid, P. Wagner, S. Brucker, D. Wallwiener and M. Hoopmann. Ultrasound Obstet Gynecol 2018; 51: 437-444

Ultrasound Obstet Gynecol. 2018 Apr;51(4):436. doi: 10.1002/uog.19027.

Author

L Hui^{1

2

3}

Affiliations

¹ University of Melbourne, Department of Perinatal Medicine, Mercy Hospital for Women, Melbourne, Australia.
² Public Health Genetics, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
³ Department of Obstetrics and Gynaecology, The Northern Hospital, Epping, Victoria, Australia.

PMID: 29634092
DOI: 10.1002/uog.19027

No abstract available

Publication types

Comment

MeSH terms

Cell-Free Nucleic Acids*
Female
Humans
Pregnancy
Pregnancy Trimester, First*
Risk Assessment
Ultrasonography

Substances

Cell-Free Nucleic Acids